Efficacy and Safety of a 12-Week Therapy with a New Formulation of Fluticasone Propionate at Doses of 125 and 250 μg Administered through a New Generation Cyclohaler Twice Daily, in Comparison to Fluticasone Propionate 500 μg Dry Powder Inhaler Twice Dail in Patients with Moderate Asthma
Advances in Respiratory Medicine